2025 annual financial data
BioMarin Pharmaceutical 2025 Net margin
Direct answer
Net margin was 10.83%.
Operating income was 533,477,999 USD and net income was 348,901,000 USD.
Operating cash flow was 827,994,000 USD.
Get free BioMarin Pharmaceutical email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 3,221,253,000 USD
- Operating income
- 533,477,999 USD
- Net income
- 348,901,000 USD
- Operating cash flow
- 827,994,000 USD
Explore related company data
View all 2025 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all BioMarin Pharmaceutical financial years